Negative prognostic factors in colorectal carcinoma: An analysis of 448 patients

被引:4
作者
Caliskan, Cemil [1 ]
Guler, Necdet [1 ]
Karaca, Can [1 ]
Makay, Ozer [1 ]
Firat, Ozgur [1 ]
Korkut, Mustafa A. [1 ]
机构
[1] Ege Univ, Sch Med, Dept Gen Surg, Div Proctol, Izmir, Turkey
关键词
Colorectal cancer; Prognosis; Survive; COLON-CANCER; MULTIVARIATE-ANALYSIS; SURVIVAL; MANAGEMENT; MORTALITY; RESECTION; CA-19-9; RECTUM; CEA; AGE;
D O I
10.1007/s12262-010-0052-1
中图分类号
R61 [外科手术学];
学科分类号
摘要
Colorectal carcinoma (CRC) is the most frequent malignancy of the gastrointestinal tract. Prognostic researches are carried out for choosing the optimum therapy, evaluating therapy results and comparing multicentre results for better qualification in the therapy of the disease. In this study, 448 patients, whose surgery and follow-up was performed by the same correspondent surgeon between the years 1995 and 2003, were retrospectively analyzed. Age, presence of comorbidity, weight loss, emergency admission, high serum CEA and CA 19-9 levels, neighboring organ invasion, operation type, major morbidity, tumor size and type, lymph node metastases, venous and perineural invasion, Dukes' classification and local recurrence and distant metastasis during follow-up are found to be significant negative factors affecting prognosis of the CRC patient. Therapy results of the CRC are evaluated by survival times regardless of the therapy method selected for each individual. In our study we tried to find out negative prognostic factors by researching possible factors affecting disease free survival time for CRC. Since our understanding of factors that have an impact on prognosis increases, we are hoping to improve survival.
引用
收藏
页码:243 / 248
页数:6
相关论文
共 26 条
[1]   Colorectal cancer survival trends in Norway 1958-1997 [J].
Angell-Andersen, E ;
Tretli, S ;
Coleman, MP ;
Langmark, F ;
Grotmol, T .
EUROPEAN JOURNAL OF CANCER, 2004, 40 (05) :734-742
[2]  
[Anonymous], TECH COLOPROCTOL
[3]   Surgical technique and survival in patients having a curative resection for colon cancer [J].
Bokey, EL ;
Chapuis, PH ;
Dent, OF ;
Mander, BJ ;
Bissett, IP ;
Newland, RC .
DISEASES OF THE COLON & RECTUM, 2003, 46 (07) :860-866
[4]   Reducing the incidence and mortality of colon cancer: Mass screening and colonoscopic polypectomy [J].
Cappell, Mitchell S. .
GASTROENTEROLOGY CLINICS OF NORTH AMERICA, 2008, 37 (01) :129-+
[5]   CEA, CA 242, CA 19-9, CA 72-4 and hCGβ in the diagnosis of recurrent colorectal cancer [J].
Carpelan-Holmström, M ;
Louhimo, J ;
Stenman, UH ;
Alfthan, H ;
Järvinen, H ;
Haglund, C .
TUMOR BIOLOGY, 2004, 25 (5-6) :228-234
[6]  
Compton CC, 2000, ARCH PATHOL LAB MED, V124, P1016
[7]  
Cunningham C, 2007, MEDICINE, V35, P306
[8]   Age-associated prognosis following curative resection for colorectal cancer [J].
Demetriades H. ;
Kanellos I. ;
Vasiliadis K. ;
Angelopoulos S. ;
Vergos O. ;
Kanellos D. ;
Betsis D. .
Techniques in Coloproctology, 2004, 8 (Suppl 1) :S144-S146
[9]   Clinical utility of biochemical markers in colorectal cancer: European Group on Tumour Markers (EGTM) guidelines [J].
Duffy, MJ ;
van Dalen, A ;
Haglund, C ;
Hansson, L ;
Klapdor, R ;
Lamerz, R ;
Nilsson, O ;
Sturgeon, C ;
Topolcan, O .
EUROPEAN JOURNAL OF CANCER, 2003, 39 (06) :718-727
[10]  
HUNTER JA, 1987, AM J SURG, V154, P67